Geselecteerde datamodellen

U moet ingelogd zijn om meerdere datamodellen te selecteren en die te downloaden of te analyseren.

93 Zoekresultaten.
Relevantie Beoordeling Nieuwe eerst Oude eerst

CALGB: CHANGES IN FUNCTION FORM [80303] NCT00088894

- 29-06-15 - 1 Formulier, 4 Itemgroepen, 16 Data-elementen, 1 Taal
Itemgroepen: Header, Patient demographics, CHANGES IN FUNCTION, Footer module
CALGB: CHANGES IN FUNCTION FORM [80303] NCT00088894 Gemcitabine With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=D6000337-794D-6FBE-E034-0003BA12F5E7

PATIENT DIARY [CALGB 80303] NCT00088894

- 08-06-15 - 1 Formulier, 8 Itemgroepen, 36 Data-elementen, 1 Taal
Itemgroepen: Reporting period, OVERNIGHT HOSPITAL STAYS AND EMERGENCY ROOM VISITS, Reporting period, OUTPATIENT AND HOME VISITS, Reporting period, EXAMINATION DATA, Reporting period, OPERATING ROOM DATA
PATIENT DIARY [CALGB 80303] NCT00088894 Gemcitabine With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=D602AE44-4EF3-3C9E-E034-0003BA12F5E7

Assessment Compliance Form NCT00057876

- 03-06-15 - 1 Formulier, 7 Itemgroepen, 32 Data-elementen, 1 Taal
Itemgroepen: ECOG clinical trial administrative data, data amendment, If Assessment was completed, If Assessment is intended to be self-administered, If Assessment was not completed, Comment, CCRR MODULE
Assessment Compliance Form NCT00057876 Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A624C73B-3251-3CE8-E034-0003BA0B1A09

Assessment Compliance Form NCT00058149

- 03-06-15 - 1 Formulier, 7 Itemgroepen, 32 Data-elementen, 1 Taal
Itemgroepen: ECOG clinical trial administrative data, data amendment, If Assessment was completed, If Assessment is intended to be self-administered, If Assessment was not completed, Comment, CCRR MODULE
Assessment Compliance Form NCT00058149 A Phase III, Randomized Study of Gemcitabine (Fixed-Dose Rate Infusion) and Oxaliplatin (NSC 266046) Versus Gemcitabine (Fixed-Dose Rate Infusion) Versus Gemcitabine (30-Minute Infusion) in Pancreatic Carcinoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A6276EB5-A819-3D71-E034-0003BA0B1A09

Long-Term Follow-up Form NCT00057876

- 28-07-15 - 1 Formulier, 10 Itemgroepen, 29 Data-elementen, 1 Taal
Itemgroepen: Header, Data amendment, Vital Status, Disease Follow-up Status, Notice of Progression, Notice of New Primary, Toxicity, Non-Protocol Therapy, Comments, CCRR MODULE
Long-Term Follow-up Form NCT00057876 Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A6241793-87BB-3BE3-E034-0003BA0B1A09

NCT01013649 RTOG 0848 Phase III Pancreas-Resected + Adjuvant Treatment Follow-up Form (F1)

- 08-07-15 - 1 Formulier, 7 Itemgroepen, 41 Data-elementen, 1 Taal
Itemgroepen: RTOG clinical trial administrative data, Current Disease Status, Events, New primary cancer, Additional Non Protocol Treatment, Adverse Events, Footer Module
NCT01013649 RTOG 0848 Phase III Pancreas-Resected + Adjuvant Treatment Follow-up Form (F1) Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=688EFF5A-8D74-8C2D-E040-BB89AD4304E2

CALGB: SURVIVAL DATA FORM [80303] NCT00088894

- 08-07-15 - 1 Formulier, 4 Itemgroepen, 13 Data-elementen, 1 Taal
Itemgroepen: Header, Patient demographics, Patient status, Footer module
CALGB: SURVIVAL DATA FORM [80303] NCT00088894 Gemcitabine With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=D5F16DBD-40A4-62FE-E034-0003BA12F5E7

CALGB: 80303 FOLLOW-UP FORM NCT00088894

- 05-07-15 - 1 Formulier, 5 Itemgroepen, 36 Data-elementen, 1 Taal
Itemgroepen: Header, Patient demographics, TREATMENT DATA, EXAMINATION DATA, TUMOR RESPONSE DATA
CALGB: 80303 FOLLOW-UP FORM NCT00088894 Gemcitabine With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=D5EC9696-FBE6-0D66-E034-0003BA12F5E7

S0205 Notice of Death NCT00075686

- 03-07-15 - 1 Formulier, 5 Itemgroepen, 23 Data-elementen, 1 Taal
Itemgroepen: Header, Date of death, CAUSES OF DEATH, Notes, CCRR MODULE
S0205 Notice of Death NCT00075686 S0205 Gemcitabine With or Without Cetuximab as First-Line Therapy in Treating Patients With Locally Advanced Unresectable or Metastatic Adenocarcinoma of the Pancreas Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A11CBC94-4007-1D74-E034-080020C9C0E0

S0205 Follow Up Form NCT00075686

- 03-07-15 - 1 Formulier, 4 Itemgroepen, 23 Data-elementen, 1 Taal
Itemgroepen: SWOG clinical trial administrative data, Miscellaneous Patient Information, Comments, CCRR MODULE
S0205 Follow Up Form NCT00075686 S0205 Gemcitabine With or Without Cetuximab as First-Line Therapy in Treating Patients With Locally Advanced Unresectable or Metastatic Adenocarcinoma of the Pancreas Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A11B693E-8E8F-02FA-E034-080020C9C0E0

CALGB: NOTIFICATION OF DEATH [80303] NCT00088894

- 29-06-15 - 1 Formulier, 4 Itemgroepen, 15 Data-elementen, 1 Taal
Itemgroepen: Header, Patient demographics, Death Assessment, Comments
CALGB: NOTIFICATION OF DEATH [80303] NCT00088894 Gemcitabine With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=D5F17800-793F-633B-E034-0003BA12F5E7

SOUTHWEST ONCOLOGY GROUP FOLLOW-UP TUMOR ASSESSMENT FORM (S0205) NCT00075686

- 12-06-15 - 1 Formulier, 6 Itemgroepen, 24 Data-elementen, 1 Taal
Itemgroepen: Header, TARGET LESIONS, NON-TARGET DISEASE, NEW LESIONS (specify site), Symptomatic deterioration, Comments
SOUTHWEST ONCOLOGY GROUP FOLLOW-UP TUMOR ASSESSMENT FORM (S0205) NCT00075686 S0205 Gemcitabine With or Without Cetuximab as First-Line Therapy in Treating Patients With Locally Advanced Unresectable or Metastatic Adenocarcinoma of the Pancreas Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F2EA530F-C553-139C-E034-0003BA3F9857

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial